Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
|
+$984M |
| 2 |
State Street Utilities Select Sector SPDR ETF
XLU
|
+$406M |
| 3 |
iShares 20+ Year Treasury Bond ETF
TLT
|
+$363M |
| 4 |
Comcast
CMCSA
|
+$305M |
| 5 |
DuPont de Nemours
DD
|
+$229M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$5.98B |
| 2 |
Linde
LIN
|
+$1.14B |
| 3 |
iShares Russell 2000 ETF
IWM
|
+$976M |
| 4 |
AGN
Allergan plc
AGN
|
+$735M |
| 5 |
iShares iBoxx $ Investment Grade Corporate Bond ETF
LQD
|
+$469M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 9.7% |
| 2 | Financials | 4.92% |
| 3 | Consumer Discretionary | 4.46% |
| 4 | Healthcare | 4.33% |
| 5 | Communication Services | 4.22% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
RDS.B
2126
DELISTED
Royal Dutch Shell PLC ADS Class B
RDS.B
| $1.97M | ﹤0.01% |
64,623
+64,123
| +12,825% | +$2.1M |
|
2127
CALL
Cracker Barrel
CBRL
$1.26B
| $1.96M | ﹤0.01% |
17,700
-77,000
| -81% | -$7.63M |
|
2128
US Foods
USFD
$24B
| $1.96M | ﹤0.01% |
99,359
-48,438
| -33% | -$926K |
|
2129
CALL
iShares MSCI Mexico ETF
EWW
$1.91B
| $1.96M | ﹤0.01% |
61,400
-81,200
| -57% | -$2.47M |
|
2130
PUT
Freeport-McMoran
FCX
$98.3B
| $1.96M | ﹤0.01% |
169,100
-914,700
| -84% | -$8.38M |
|
2131
Cannae Holdings
CNNE
$643M
| $1.95M | ﹤0.01% |
47,539
+22,988
| +94% | +$786K |
|
|
LSXMA
2132
DELISTED
Liberty Media Corporation Series A Liberty SiriusXM Common Stock
LSXMA
| $1.95M | ﹤0.01% |
76,951
-822,842
| -91% | -$20.1M |
|
2133
WaFd
WAFD
$2.75B
| $1.95M | ﹤0.01% |
72,514
+26,405
| +57% | +$680K |
|
|
SFBS
2134
ServisFirst Bancshares
SFBS
$4.84B
| $1.95M | ﹤0.01% |
54,369
+1,430
| +3% | +$47.2K |
|
2135
PUT
iShares Biotechnology ETF
IBB
$9.79B
| $1.94M | ﹤0.01% |
14,200
-88,500
| -86% | -$11.3M |
|
|
HTO
2136
H2O America
HTO
$2.56B
| $1.94M | ﹤0.01% |
31,244
+8,075
| +35% | +$485K |
|
2137
United Bankshares
UBSI
$6.59B
| $1.93M | ﹤0.01% |
69,832
+37,301
| +115% | +$1M |
|
|
SUM
2138
CALL
DELISTED
Summit Materials, Inc. Class A Common Stock
SUM
| $1.93M | ﹤0.01% |
+122,040
| New | +$1.75M |
|
|
XENT
2139
DELISTED
Intersect ENT, Inc
XENT
| $1.93M | ﹤0.01% |
142,270
-26,262
| -16% | -$306K |
|
|
TCDA
2140
DELISTED
Tricida, Inc. Common Stock
TCDA
| $1.93M | ﹤0.01% |
70,066
+37,385
| +114% | +$1.02M |
|
|
AMWD
2141
DELISTED
American Woodmark
AMWD
| $1.92M | ﹤0.01% |
25,408
+1,138
| +5% | +$65.1K |
|
|
PRAH
2142
DELISTED
PRA Health Sciences, Inc.
PRAH
| $1.92M | ﹤0.01% |
19,755
-1,125
| -5% | -$105K |
|
2143
CALL
General Motors
GM
$77.3B
| $1.92M | ﹤0.01% |
75,800
-600,400
| -89% | -$14.6M |
|
2144
United Therapeutics
UTHR
$22.8B
| $1.92M | ﹤0.01% |
15,830
-1,431
| -8% | -$161K |
|
2145
CALL
Direxion Daily Small Cap Bull 3x ETF
TNA
$1.46B
| $1.91M | ﹤0.01% |
69,800
-6,000
| -8% | -$137K |
|
|
CVSA
2146
Covista Inc
CVSA
$4.69B
| $1.91M | ﹤0.01% |
61,275
+4,824
| +9% | +$151K |
|
2147
PUT
Viatris
VTRS
$18.7B
| $1.91M | ﹤0.01% |
118,700
-253,700
| -68% | -$4.11M |
|
|
UCTT
2148
Ultra Clean Holdings
UCTT
$3.85B
| $1.91M | ﹤0.01% |
84,257
-17,453
| -17% | -$332K |
|
|
SUM
2149
DELISTED
Summit Materials, Inc. Class A Common Stock
SUM
| $1.9M | ﹤0.01% |
120,183
+80,476
| +203% | +$1.15M |
|
2150
Sanmina
SANM
$11B
| $1.9M | ﹤0.01% |
75,911
-13,156
| -15% | -$346K |
|
Similar funds
Barclays's Q2 2020 Portfolio in Review
As of Q2 2020, Barclays held 6,627 positions worth $129B, up 2.3% from $127B the previous quarter. Its ten largest holdings account for 34% of the portfolio.
Barclays withdrew a net $22.7B in Q2 2020, closing 960 positions and reducing 2,655 holdings. Its most notable exit was Allergan plc, an estimated $735M position sold in full.
By sector, the portfolio is most concentrated in Technology at 9.7% of assets, up from 8.3% a quarter earlier, followed by Financials and Consumer Discretionary.
Against the trend, Barclays opened a new position in iShares MSCI ACWI ex US ETF worth $123M.
- Barclays's largest Q2 2020 buy was iShares MSCI ACWI ex US ETF: 2,853,067 shares worth $123M.
- Barclays added most to iShares iBoxx $ High Yield Corporate Bond ETF in Q2 2020, an estimated $984M increase.
- Barclays's biggest Q2 2020 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $5.98B.
- Barclays fully exited Allergan plc in Q2 2020, selling an estimated $735M.
- Barclays's ten largest holdings make up 34% of its $129B portfolio in Q2 2020.
- Barclays opened 468 new positions and closed 960 in Q2 2020.
- Barclays's portfolio value rose 2.3% quarter-over-quarter to $129B.
Based on Barclays's 13F filing for Q2 2020, filed 12 Aug 2020.